Investment Summary |
|
|---|---|
| Date | 2020-12-03 |
| Target | Zenitech |
| Sector | Information Technology |
| Investor(s) | Sovereign Capital Partners |
| Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 1.0B GBP |
| Size | Large |
| Type | Sector Agnostic |
Sovereign Capital Partners (SCP) is a private equity firm that specializes in buy and build opportunities throughout the UK. The Firm targets consolidation strategies in the education and training, healthcare, and outsourced business services sectors. SCP looks to invest £10 to £120 million per transaction. Sovereign Capital Partners was formed in 2001 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 49 of 55 |
| Sector (Information Technology) | 1 of 4 |
| Type (Growth Capital) | 9 of 13 |
| Country (United Kingdom) | 45 of 50 |
| Year (2020) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-11-20 |
Brighton Institute
London, United Kingdom Brighton Institute is a provider of modern music further and higher education. It offers a broad range of qualifications in Modern Music, with courses delivered by tutors who are active professional musicians. Brighton Institute was established in 2001 and is based in London, United Kingdom. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-04 |
Bioscript
Cheshire, United Kingdom Bioscript is an international provider of medical communications and regulatory writing services for pharmaceutical companies. The business assists clients in their communications with regulatory authorities as well as educating the medical sector on pharmaceutical products that are in mid-to-late-stage clinical trials and subsequently supporting these products, post-market launch, to maintain and grow sales throughout the lifecycle of the drug. Bioscript was founded in 2005 and is based in Cheshire, United Kingdom. |
Buy | - |
